Early Oral Intake Following Cesarean Surgery

This study has been completed.
Sponsor:
Information provided by:
Tehran University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00370708
First received: August 31, 2006
Last updated: September 6, 2006
Last verified: April 2004
  Purpose

In this study we are trying to compare the safety and financial benefit of starting the realimentation early versus conventional oral intake following the Cesarean surgery in Iran.


Condition Intervention
Obstetrics
Surgery
Procedure: Oral Intake following admittance to the postpartum ward

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Supportive Care
Official Title: Early Oral Intake Following Elective Cesarean Surgery in Iranian Women; the Economic Burdens and Patient Satisfaction

Further study details as provided by Tehran University of Medical Sciences:

Primary Outcome Measures:
  • Tolerance of Oral Intake

Study Start Date: April 2003
Estimated Study Completion Date: February 2004
Detailed Description:

Cesarean delivery is announced to constitute 50% of deliveries in the Capital and 39% of all the deliveries nationwide, which is far beyond the acceptable international normal range, according to the official site of the Ministry of Health and Medical Education of the Islamic Republic of Iran [http://www.mohme.gov.ir/HNDC/Indicators/Simaye_Salamt/Simaye_Salamat.htm]. This high rate of elective cesarean deliveries might be due to several reasons which are far beyond the scope of this study. Here we tried to see whether the reduction in the time of hospitalization for these patients is safe at the expense of earlier oral realimentation and to see whether this strategy increases the patients' satisfaction or not.

  Eligibility

Ages Eligible for Study:   20 Years to 35 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Women who had elective cesarean deliveries under regional anesthesia

Exclusion Criteria:

  1. Receiving general anesthesia, magnesium sulfate or insulin.
  2. Coming across an intraoperative bowel injury.
  3. Having any medical or gastrointestinal problem that prohibits early feeding
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00370708

Locations
Iran, Islamic Republic of
Department of Obstetrics and Gynecology, Arash Hospital
Tehran, Iran, Islamic Republic of, 19986
Sponsors and Collaborators
Tehran University of Medical Sciences
Investigators
Principal Investigator: Afsaneh Tehranian, Assist Pro Department of Obstetrics and Gynecology, Arash Hospital, Tehran University of Medical Sciences, Tehran/Iran
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00370708     History of Changes
Other Study ID Numbers: 1383FK
Study First Received: August 31, 2006
Last Updated: September 6, 2006
Health Authority: Iran: Ethics Committee

Keywords provided by Tehran University of Medical Sciences:
Cesarean
Oral
Intake

ClinicalTrials.gov processed this record on August 26, 2014